期刊文献+

天然磷脂酰肌醇3-激酶抑制剂的筛选

Screening of Natural Phosphatidylinositol 3-kinase Inhibitor
下载PDF
导出
摘要 为肿瘤特异性药物研制提供参考,以40种中药材总生物碱提取物及12种天然viridin类似物为材料,使用体外激酶测定方法评估化合物对PI3K的抑制强度,通过使用基于萤光素酶的发光测定法测量激酶反应后产生ADP的量来确定PI3K酶活性,以寻求天然的磷脂酰肌醇3-激酶(PI3K)高活性的抑制剂。结果表明:槲寄生、马齿苋、粉防己、大青叶和川芎的总生物碱提取物及化合物12(Wortmannine C)具有明显的PI3K抑制活性,其抑制率分别为81.0%、80.8%、80.7%、86.6%、77.5%和74%,其IC50在0.1~20.6μg/mL。其余的植物总生物碱及天然化合物无显著的抗PI3K活性。 12 natural viridian analogs and 40 total alkaloid extracts from 40 traditional Chinese medicinal materials were used to detect their inhibition strength against phosphatidylinositol 3-kinase(PI3K)by an vitro kinase assay and the activity of PI3K enzyme was determined by measuring ADP amount produced from kinase reaction by means of luciferase-based luminescence assay to provide a refereace for development of tumor-specific drugs and screen inhibitors with higher activity against PI3K.Result:The inhibition rate of total alkaloid extracts from Viscum coloratum,Portulaca oleracea,Stephania tetrandra,Isatis indigotica and Ligusticum chuanxiong and Compound 12(Wortmannine C)against PI3K is 81.0%,80.8%,80.7%,86.6%,77.5%and 74%respectively and the IC 50 is 0.1-20.6μg/mL.Other tested total alkaloid extracts and natural compounds all have no significant anti-PI3K activity.
作者 杨立军 杨中铎 YANG Lijun;YANG Zhongduo(College of Life Science and Engineering,Lanzhou University of Technology,Lanzhou,Gamsu 730050,China)
出处 《贵州农业科学》 CAS 2019年第7期127-130,共4页 Guizhou Agricultural Sciences
基金 国家自然科学基金项目“踝节菌属真菌中具有PI3K抑制活性的新型Viridin类似物的高通量发现研究”(21762027)
关键词 磷脂酰肌醇3-激酶(PI3K) 抑制剂 生物碱 phosphatidylinositol 3-kinase(PI3K) inhibitor alkaloid
  • 相关文献

参考文献3

二级参考文献52

  • 1Vivanco I, Sawyers CL. The phosphatidylinositol 3- kinase-AKT pathway in human cancer [J]. Nat Rev Cancer, 2002,2(7) :489-501.
  • 2Picinato MC, Hirata AE, Cipolla J, et al. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets [J]. J Pin Res, 2008,44(1):88-94.
  • 3Zhou X, Tna M, Stone Hawthorne V, et al. Activation of the Akt/mammalian target of rapamycin /4E-BP1 pathway bj ErbB2 overexpression predicts tumor progression in breast cancers [J]. Clin Cancer Res, 2004,10(20) :6779-6788.
  • 4Park CM, Park M J, Kwak H J, et al. Ionizing radiation enhances matrix metallop-roteinase-2 Secretion and invasion of Glioma cells through src / epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways [J]. Cancer Res, 2006,66(17):8511-8519.
  • 5Walker EH, Pacold ME, Perisic O, et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine [J]. Mol Cell, 2000,6(4):909-919.
  • 6Hartley KO, Gell D, dependent protein kinase of phosphatidylinosito! Smith GC, et al. DNA catalytic subunit: a relative 3-kinase and the ataxia telangiectasia gene product [J]. Cell, 1995,82 (5): 849-856.
  • 7Brunn GJ, Williams J, Sabers C, et al. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002 [J]. EMBO J, 1996, 15(19) : 5256-5267.
  • 8Sarkaria JN, Tibbetts RS, Busby EC, et al. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin [J]. Cancer Res, 1998,58 (19) : 4375-4382.
  • 9Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage [J]. Science, 1998,281 (5383) : 1674-1677.
  • 10Garlich JR, De P, Dey N, et al. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity [J]. Cancer Res, 2008,68( 1 ) :206-215.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部